Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

AliExpress lĩnh án phạt kỷ lục tại EU vì hàng giả

AliExpress lĩnh án phạt kỷ lục tại EU vì hàng giả

Thế giới
(Baothanhhoa.vn) - Ủy ban châu Âu (EC) đã áp mức phạt kỷ lục 550 triệu euro (khoảng 629 triệu USD) đối với nền tảng AliExpress của “gã khổng lồ” thương mại điện tử Trung Quốc Alibaba, do không ngăn chặn hiệu quả việc rao bán các sản phẩm bất hợp pháp, hàng giả và hàng...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh